Canada Markets closed

Zoetis Inc. (ZTS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
167.80-3.20 (-1.87%)
At close: 04:03PM EST
167.19 -0.61 (-0.36%)
After hours: 06:38PM EST

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees12,100

Key Executives

NameTitlePayExercisedYear Born
Ms. Kristin C. PeckCEO & Director3.86M7.64M1971
Mr. Glenn C. DavidExec. VP and Group Pres of International Operations, Aquaculture, BioDevices & Pet Insurance1.9M2.51M1972
Mr. Wetteny N. JosephExec. VP & CFO2.91MN/A1972
Ms. Heidi C. ChenExec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics1.39M5.56M1967
Ms. Roxanne LaganoExec. VP and Chief HR Officer & Global OperationsN/AN/A1965
Ms. Wafaa MamilliExec. VP and Chief Information & Digital OfficerN/AN/A1967
Mr. Steven FrankVP of Investor RelationsN/AN/AN/A
Mr. William PriceVP & Chief Communications OfficerN/AN/AN/A
Mr. Timothy J. BettingtonExec. VP and Pres of U.S. Operations & Global Customer ExperienceN/AN/A1974
Mr. Abhay U. NayakExec. VP and Head of Strategy, Accelerated Growth & Commercial Devel.N/AN/A1988
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate Governance

Zoetis Inc.’s ISS Governance QualityScore as of October 1, 2022 is 3. The pillar scores are Audit: 5; Board: 1; Shareholder Rights: 7; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.